Satrio Adi Wicaksono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Satrio Adi Wicaksono has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Widya Istanto Nurcahyo
Department of Anesthesiology and Intensive Care, Dr. Kariadi General Hospital, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
5 shared publications Sulistiyati Bayu Utami
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
4 shared publications- Chandra Hermawan Manapa
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Diponegoro University, Semarang, Central Java, Indonesia
3 shared publications - Sulistiyati Bayu Utami
Department of Cardiology and Vascular Medicine. Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
3 shared publications - Taufik Eko Nugroho
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia / Dr. Kariadi General Hospital Semarang, Indonesia ; Diponegoro National Hospital Semarang, Indonesia
3 shared publications Erwin Kresnoadi
Univ Diponegoro, Fac Med, Dept Anesthesiol & Intens Care, Semarang, Indonesia
2 shared publications
Latest Publications
- Open Access
- 19 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Efficacy and Safety of Magnesium Sulfate as a Quadratus Lumborum Block Adjuvant: A Systematic Review and Meta-analysis (Preprint)
BACKGROUND Quadratus lumborum block (QLB) is increasingly used for abdominal and pelvic surgery, but the duration of a single-shot block may be limited. Magnesium sulfate (MgSO4) has been proposed as an injectate adjuvant because of its N-methyl-D-aspartate (NMDA) receptor antagonism and calcium-channel modulation. Evidence specific to QLB remains limited. OBJECTIVE To evaluate the efficacy and reported safety of MgSO4 added to the QLB injectate in adult surgical patients. METHODS PubMed/MEDLINE, Scopus, Cochrane Library/CENTRAL, SpringerLink, and ProQuest were searched from inception to June 20, 2026. Randomized trials comparing QLB with versus without MgSO4 in the injectate were included. The primary outcome was postoperative opioid consumption. Secondary outcomes were rescue analgesia, pain scores, postoperative nausea or vomiting (PONV), analgesic duration, and adverse events. Risk of bias was assessed using RoB 2 and certainty using GRADE. Dichotomous outcomes were pooled as risk ratios (RRs)with DerSimonian–Laird random-effects models. Knapp–Hartung inference was used for sensitivity analysis. Outcomes measured over clinically non-equivalent periods were synthesized narratively. RESULTS Three randomized trials involving 244 patients were included; 162 contributed to the main comparison. Two trials reported cumulative opioid consumption, but pooling was inappropriate because one measured 24-hour sufentanil consumption and the other measured 48-hour morphine consumption. Both favored MgSO4. In the 24-hour trial, sufentanil consumption was reduced by 7.31 μg (95% CI −13.27 to −1.35). In the 48-hour trial, mean morphine consumption was 2.38 mg with MgSO4 versus 5.47 mg with control. Rescue analgesia favored MgSO4 in the primary model (RR 0.66, 95% CI 0.50–0.87; I²=0%; 3 trials). However, one trial contributed 93.8% of the weight, and the Knapp–Hartung analysis was no longer statistically significant (RR 0.61, 95% CI 0.23–1.59). Leave-one-out analyses also showed instability. The effect on PONV remained inconclusive (RR 0.57, 95% CI 0.26–1.27; I²=21.6%; 2 trials). Pain and analgesic-duration outcomes were heterogeneous and synthesized narratively. No serious adverse event was clearly attributed to MgSO4, although safety surveillance was limited. Certainty ranged from low to very low. CONCLUSIONS MgSO4 added to the QLB injectate may reduce postoperative analgesic requirements, but the evidence is based on few small and clinically heterogeneous trials. The rescue-analgesia signal was statistically fragile. Larger standardized trials are needed before routine clinical use can be recommended. CLINICALTRIAL The review was registered in PROSPERO (CRD420261334324).
- 19 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEfficacy and Safety of Magnesium Sulfate as a Quadratus Lumborum Block Adjuvant: A Systematic Review and Meta-analysis (Preprint)
BACKGROUND Quadratus lumborum block (QLB) is increasingly used for abdominal and pelvic surgery, but the duration of a single-shot block may be limited. Magnesium sulfate (MgSO4) has been proposed as an injectate adjuvant because of its N-methyl-D-aspartate (NMDA) receptor antagonism and calcium-channel modulation. Evidence specific to QLB remains limited. OBJECTIVE To evaluate the efficacy and reported safety of MgSO4 added to the QLB injectate in adult surgical patients. METHODS PubMed/MEDLINE, Scopus, Cochrane Library/CENTRAL, SpringerLink, and ProQuest were searched from inception to June 20, 2026. Randomized trials comparing QLB with versus without MgSO4 in the injectate were included. The primary outcome was postoperative opioid consumption. Secondary outcomes were rescue analgesia, pain scores, postoperative nausea or vomiting (PONV), analgesic duration, and adverse events. Risk of bias was assessed using RoB 2 and certainty using GRADE. Dichotomous outcomes were pooled as risk ratios (RRs)with DerSimonian–Laird random-effects models. Knapp–Hartung inference was used for sensitivity analysis. Outcomes measured over clinically non-equivalent periods were synthesized narratively. RESULTS Three randomized trials involving 244 patients were included; 162 contributed to the main comparison. Two trials reported cumulative opioid consumption, but pooling was inappropriate because one measured 24-hour sufentanil consumption and the other measured 48-hour morphine consumption. Both favored MgSO4. In the 24-hour trial, sufentanil consumption was reduced by 7.31 μg (95% CI −13.27 to −1.35). In the 48-hour trial, mean morphine consumption was 2.38 mg with MgSO4 versus 5.47 mg with control. Rescue analgesia favored MgSO4 in the primary model (RR 0.66, 95% CI 0.50–0.87; I²=0%; 3 trials). However, one trial contributed 93.8% of the weight, and the Knapp–Hartung analysis was no longer statistically significant (RR 0.61, 95% CI 0.23–1.59). Leave-one-out analyses also showed instability. The effect on PONV remained inconclusive (RR 0.57, 95% CI 0.26–1.27; I²=21.6%; 2 trials). Pain and analgesic-duration outcomes were heterogeneous and synthesized narratively. No serious adverse event was clearly attributed to MgSO4, although safety surveillance was limited. Certainty ranged from low to very low. CONCLUSIONS MgSO4 added to the QLB injectate may reduce postoperative analgesic requirements, but the evidence is based on few small and clinically heterogeneous trials. The rescue-analgesia signal was statistically fragile. Larger standardized trials are needed before routine clinical use can be recommended. CLINICALTRIAL The review was registered in PROSPERO (CRD420261334324).
- Open Access
- 19 March 2025
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 14 (2) , 513-522
The correlation between cardiopulmonary bypass time and lactate levels and the length of stay in intensive care unit in post-operative patients of coronary artery bypass grafting surgery
Link of Video https://youtu.be/IyRnt5R0zR8 Background: Coronary artery bypass grafting surgery (CABG) is one surgical management for coronary artery disease (CAD). Hyperlactataemia in CABG is associated with poor postoperative outcomes. This study aimed to correlate cardiopulmonary bypass (CPB) time and serum lactate levels to the length of stay (LOS) in the intensive care unit (ICU) in patients with post-CABG. Methods: This was a cohort study of 358 patients with post-CABG from January 2016 until December 2021 in Dr. Kariadi Hospital Semarang, Indonesia. Subjects were selected by consecutive sampling. The correlation between CPB time and serum lactate levels, between CPB time and LOS in ICU, and between serum lactate levels and LOS in ICU were analyzed by non-parametric Spearman correlation test. Subjects were then divided into 2 groups, i.e. groups with lactate levels <4.0 mmol/L and≥4.0 mmol/L. The differences in LOS in the ICU were analyzed between both groups using the non-parametric Mann-Whitney test. Results: There was a correlation between CPB time and serum lactate levels in ICU (r=0.302, p=0.000), between serum lactate levels and LOS in ICU (r=0.194, p=0.003), and between CPB time and LOS in ICU (r=0.373, p=0.005). There was a longer CPB time in the group with lactate levels ≥4 mmol/L compared to that with lactate levels <4 mmol/L (70.7 ± 5.12 versus 66.9 ± 7.28, p=0.006). There was a longer LOS in ICU (3.8 ± 3.17 versus 3.1 ± 1.21, p=0.143) in a group with lactate levels ≥4 mmol/L compared to that with lactate levels <4 mmol/L, although it was not significant. Conclusion: There was a correlation between CPB time and LOS, and between serum lactate levels and LOS in ICU in patients after CABG. If confirmed by further findings, lactate levels might be a predictor for the outcome for patients after CABG including a longer LOS in ICU.
- 19 March 2025
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 14 (2) , 513-522
Open AccessThe correlation between cardiopulmonary bypass time and lactate levels and the length of stay in intensive care unit in post-operative patients of coronary artery bypass grafting surgery
Link of Video https://youtu.be/IyRnt5R0zR8 Background: Coronary artery bypass grafting surgery (CABG) is one surgical management for coronary artery disease (CAD). Hyperlactataemia in CABG is associated with poor postoperative outcomes. This study aimed to correlate cardiopulmonary bypass (CPB) time and serum lactate levels to the length of stay (LOS) in the intensive care unit (ICU) in patients with post-CABG. Methods: This was a cohort study of 358 patients with post-CABG from January 2016 until December 2021 in Dr. Kariadi Hospital Semarang, Indonesia. Subjects were selected by consecutive sampling. The correlation between CPB time and serum lactate levels, between CPB time and LOS in ICU, and between serum lactate levels and LOS in ICU were analyzed by non-parametric Spearman correlation test. Subjects were then divided into 2 groups, i.e. groups with lactate levels <4.0 mmol/L and≥4.0 mmol/L. The differences in LOS in the ICU were analyzed between both groups using the non-parametric Mann-Whitney test. Results: There was a correlation between CPB time and serum lactate levels in ICU (r=0.302, p=0.000), between serum lactate levels and LOS in ICU (r=0.194, p=0.003), and between CPB time and LOS in ICU (r=0.373, p=0.005). There was a longer CPB time in the group with lactate levels ≥4 mmol/L compared to that with lactate levels <4 mmol/L (70.7 ± 5.12 versus 66.9 ± 7.28, p=0.006). There was a longer LOS in ICU (3.8 ± 3.17 versus 3.1 ± 1.21, p=0.143) in a group with lactate levels ≥4 mmol/L compared to that with lactate levels <4 mmol/L, although it was not significant. Conclusion: There was a correlation between CPB time and LOS, and between serum lactate levels and LOS in ICU in patients after CABG. If confirmed by further findings, lactate levels might be a predictor for the outcome for patients after CABG including a longer LOS in ICU.
- Open Access
- 10 January 2025
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 29 (7) , 796-807
Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety
Introduction: Spinal anesthesia (SA) is widely used for lower abdominal and limb surgeries due to its rapid onset and favorable safety profile. However, because of sympathetic blockade, it frequently results in bradycardia and hypotension, increasing the risk of perioperative complications and postoperative nausea and vomiting (PONV). Intrathecal atropine has shown potential as an adjuvant to counteract these effects and improve anesthesia outcomes. This review evaluates current evidence on the safety and efficacy of intrathecal atropine in SA. Methods: MEDLINE, EMBASE, CENTRAL, Scopus, ProQuest, and Google Scholar were searched for randomized controlled trials published in English up to April 2025 on intrathecal atropine as an adjuvant in SA. The primary outcome was PONV; secondary outcomes included sensory block onset, postoperative pain, and adverse effects. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Results: Five RCTs involving 584 patients were included. Intrathecal atropine significantly reduced the incidence and severity of PONV in most studies (P < 0.05). However, it did not show significant effects on postoperative pain scores, sensory block onset, or hemodynamic parameters compared to control or other adjuvants. Adverse effects were generally mild and comparable across groups, though one study reported a higher incidence of pruritus with atropine (P < 0.001). No serious complications were observed. Nonetheless, study limitations included small sample sizes, non-standardized outcomes, and single-center designs with limited follow-up. Conclusions: Intrathecal atropine may reduce PONV after SA without serious adverse effects. However, its impact on pain, sensory block, and hemodynamics remains uncertain, warranting further large-scale, standardized trials. Abbreviations: GA: general anesthesia, RCT: randomized controlled trial, SA: Spinal anesthesia, PONV: postoperative nausea and vomiting Keywords: Adjuvant; Atropine; Complications; Intrathecal; Outcome; PONV; Postoperative Nausea and Vomiting; Spinal Anesthesia Citation: Pramadika T, Mochamat, Nurcahyo WI, Wicaksono SA, Saputra T, Manapa CH, Ksatriaputra A. Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety. Anaesth. pain intensive care 2025;29(7):796-807. DOI: 10.35975/apic.v29i7.2947
- 10 January 2025
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 29 (7) , 796-807
Open AccessIntrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety
Introduction: Spinal anesthesia (SA) is widely used for lower abdominal and limb surgeries due to its rapid onset and favorable safety profile. However, because of sympathetic blockade, it frequently results in bradycardia and hypotension, increasing the risk of perioperative complications and postoperative nausea and vomiting (PONV). Intrathecal atropine has shown potential as an adjuvant to counteract these effects and improve anesthesia outcomes. This review evaluates current evidence on the safety and efficacy of intrathecal atropine in SA. Methods: MEDLINE, EMBASE, CENTRAL, Scopus, ProQuest, and Google Scholar were searched for randomized controlled trials published in English up to April 2025 on intrathecal atropine as an adjuvant in SA. The primary outcome was PONV; secondary outcomes included sensory block onset, postoperative pain, and adverse effects. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Results: Five RCTs involving 584 patients were included. Intrathecal atropine significantly reduced the incidence and severity of PONV in most studies (P < 0.05). However, it did not show significant effects on postoperative pain scores, sensory block onset, or hemodynamic parameters compared to control or other adjuvants. Adverse effects were generally mild and comparable across groups, though one study reported a higher incidence of pruritus with atropine (P < 0.001). No serious complications were observed. Nonetheless, study limitations included small sample sizes, non-standardized outcomes, and single-center designs with limited follow-up. Conclusions: Intrathecal atropine may reduce PONV after SA without serious adverse effects. However, its impact on pain, sensory block, and hemodynamics remains uncertain, warranting further large-scale, standardized trials. Abbreviations: GA: general anesthesia, RCT: randomized controlled trial, SA: Spinal anesthesia, PONV: postoperative nausea and vomiting Keywords: Adjuvant; Atropine; Complications; Intrathecal; Outcome; PONV; Postoperative Nausea and Vomiting; Spinal Anesthesia Citation: Pramadika T, Mochamat, Nurcahyo WI, Wicaksono SA, Saputra T, Manapa CH, Ksatriaputra A. Intrathecal atropine as an adjuvant in spinal anesthesia: a systematic review of efficacy and safety. Anaesth. pain intensive care 2025;29(7):796-807. DOI: 10.35975/apic.v29i7.2947
- Open Access
- 30 November 2024
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in JAI (Jurnal Anestesiologi Indonesia)
- Vol. 16 (3) , 241-248
The Comparison between Preoperative Maltodextrine and Sugar Water Administration on Random Blood Glucose Levels in Enhanced Recovery After Cesarean Surgery (ERACS) Patients
Background: Oral carbohydrate administration reduces post-operative insulin resistance and improves post-operative recovery. Sugar water and maltodextrin are oral carbohydrates that can be given to enhanced recovery after caesarean surgery (ERACS) patients.Objective: To compare the effect between pre-operative maltodextrin treatment and sugar water treatment on random blood glucose (RBG) levels in enhanced recovery after caesarean section (ERACS) patients.Methods: A randomized control study with pre-test and post-test design was used on 48 patients who underwent ERACS surgery at Dr. Kariadi hospital Semarang Indonesia and met the inclusion and exclusion criteria. Study subjects were divided into two groups: a pre-operative maltodextrin treatment group (n=24) and a pre-operative sugar water control group (n=24). RBG levels were checked with point-of-care testing (POCT) at soon before surgery and at 2 hours after surgery. Mann-Whitney test was used to analyse the difference of RBG levels between group with Maltodextrin and group with sugar water. Wilcoxon test was used to analyse the difference of RBG levels before surgery (pre-operative RBG) and 2 hours after surgery (post-operative RBG). The p value of <0.05 was considered as statistically significant.Result: There were significant lower RBG levels in group with pre-operative maltodextrin treatment compared to group with pre-operative sugar water at soon before surgery (pre-operative) (83.5 ± 9.73 vs 96.2 ± 12.99 mg/dL, p=0.003) and at 2 hours post-operative (101.7 ± 15.81 vs 118.9 ± 28.38, p=0.035) in ERACS patients.Conclusion: If confirmed by further studies, pre-operative maltodextrin administration might provide better outcome in reducing post-operative catabolic status by reducing post-operative insulin resistance and improving RBG levels before and after ERACS compared to sugar water control.
- 30 November 2024
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in JAI (Jurnal Anestesiologi Indonesia)
- Vol. 16 (3) , 241-248
Open AccessThe Comparison between Preoperative Maltodextrine and Sugar Water Administration on Random Blood Glucose Levels in Enhanced Recovery After Cesarean Surgery (ERACS) Patients
Background: Oral carbohydrate administration reduces post-operative insulin resistance and improves post-operative recovery. Sugar water and maltodextrin are oral carbohydrates that can be given to enhanced recovery after caesarean surgery (ERACS) patients.Objective: To compare the effect between pre-operative maltodextrin treatment and sugar water treatment on random blood glucose (RBG) levels in enhanced recovery after caesarean section (ERACS) patients.Methods: A randomized control study with pre-test and post-test design was used on 48 patients who underwent ERACS surgery at Dr. Kariadi hospital Semarang Indonesia and met the inclusion and exclusion criteria. Study subjects were divided into two groups: a pre-operative maltodextrin treatment group (n=24) and a pre-operative sugar water control group (n=24). RBG levels were checked with point-of-care testing (POCT) at soon before surgery and at 2 hours after surgery. Mann-Whitney test was used to analyse the difference of RBG levels between group with Maltodextrin and group with sugar water. Wilcoxon test was used to analyse the difference of RBG levels before surgery (pre-operative RBG) and 2 hours after surgery (post-operative RBG). The p value of <0.05 was considered as statistically significant.Result: There were significant lower RBG levels in group with pre-operative maltodextrin treatment compared to group with pre-operative sugar water at soon before surgery (pre-operative) (83.5 ± 9.73 vs 96.2 ± 12.99 mg/dL, p=0.003) and at 2 hours post-operative (101.7 ± 15.81 vs 118.9 ± 28.38, p=0.035) in ERACS patients.Conclusion: If confirmed by further studies, pre-operative maltodextrin administration might provide better outcome in reducing post-operative catabolic status by reducing post-operative insulin resistance and improving RBG levels before and after ERACS compared to sugar water control.
- Open Access
- 29 August 2024
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 14 (1) , 17-25
The correlation between lactate levels and the length of stay in the intensive care unit in post-operative patients of rheumatic valvular heart disease surgery
Background: Valvular heart surgery with cardiopulmonary bypass (CPB) may be accompanied by increased serum lactate levels. Serum lactate levels can predict postoperative outcomes. This study aimed to correlate serum lactate levels to the length of stay (LOS) in the intensive care unit (ICU) in patients with rheumatic valvular heart surgery (RVHS). Method: This was a prospective cohort study of thirty (30) patients with post-cardiac surgery of RVHS from February 2016 to June 2019 in Dr. Kariadi Hospital Semarang, Indonesia. Subjects were selected by consecutive sampling. Serum lactate levels were examined in one hour after RVHS. Patients were divided into 2 groups, i.e. group with lactate levels <3.0 mmol/L and with ≥3.0 mmol/L. Patients were followed up during hospitalization. The differences in LOS in the ICU were analyzed using the Mann-Whitney test. The correlation between serum lactate levels and the LOS in the ICU was analyzed by the Spearman correlative test. Results: The average lactate level in the ICU was 3.9 ± 1.06 mmol/L. The average CPB time was 68.7 ± 8.55 minutes. The median of LOS in ICU was 3 days (range 2–6 days). There were no differences in baseline characteristics, echocardiographic, and laboratory data between both groups, except height (p=0.036), heart rate (p=0.025), and CPB time (57.40 ± 4.93 vs 71.00 ± 7.22, p=0.001). There were no significant differences in LOS in total in-hospital stay (p=0.813) and LOS in ICU stay ( p=0.132) between both groups. There was a significant positive moderate correlation between serum lactate levels and the LOS in the ICU (Spearman r=0.522, p=0.003). Conclusion: There was a moderate positive correlation between serum lactate levels and the LOS in ICU patients with RVHS. If confirmed by further studies, lactate levels may be a predictor for the outcome of RVHS.
- 29 August 2024
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 14 (1) , 17-25
Open AccessThe correlation between lactate levels and the length of stay in the intensive care unit in post-operative patients of rheumatic valvular heart disease surgery
Background: Valvular heart surgery with cardiopulmonary bypass (CPB) may be accompanied by increased serum lactate levels. Serum lactate levels can predict postoperative outcomes. This study aimed to correlate serum lactate levels to the length of stay (LOS) in the intensive care unit (ICU) in patients with rheumatic valvular heart surgery (RVHS). Method: This was a prospective cohort study of thirty (30) patients with post-cardiac surgery of RVHS from February 2016 to June 2019 in Dr. Kariadi Hospital Semarang, Indonesia. Subjects were selected by consecutive sampling. Serum lactate levels were examined in one hour after RVHS. Patients were divided into 2 groups, i.e. group with lactate levels <3.0 mmol/L and with ≥3.0 mmol/L. Patients were followed up during hospitalization. The differences in LOS in the ICU were analyzed using the Mann-Whitney test. The correlation between serum lactate levels and the LOS in the ICU was analyzed by the Spearman correlative test. Results: The average lactate level in the ICU was 3.9 ± 1.06 mmol/L. The average CPB time was 68.7 ± 8.55 minutes. The median of LOS in ICU was 3 days (range 2–6 days). There were no differences in baseline characteristics, echocardiographic, and laboratory data between both groups, except height (p=0.036), heart rate (p=0.025), and CPB time (57.40 ± 4.93 vs 71.00 ± 7.22, p=0.001). There were no significant differences in LOS in total in-hospital stay (p=0.813) and LOS in ICU stay ( p=0.132) between both groups. There was a significant positive moderate correlation between serum lactate levels and the LOS in the ICU (Spearman r=0.522, p=0.003). Conclusion: There was a moderate positive correlation between serum lactate levels and the LOS in ICU patients with RVHS. If confirmed by further studies, lactate levels may be a predictor for the outcome of RVHS.
- Open Access
- 16 July 2023
- Published by Muhammadiyah Metro University in SWARNADWIPA
- Vol. 7 (1)
MENINGKATKAN MINAT BELAJAR PESERTA DIDIK MELALUI PENERAPAN MODEL TEAM GAMES TOURNAMENT MEDIA KARTU DOMINO PADA MATA PELAJARAN SEJARAH INDONESIA KELAS XI 11 SMAN 1 GEDONGTATAAN
MENINGKATKAN MINAT BELAJAR PESERTA DIDIK MELALUI PENERAPAN MODEL TEAM GAMES TOURNAMENT MEDIA KARTU DOMINO PADA MATA PELAJARAN SEJARAH INDONESIA KELAS XI 11 SMAN 1 GEDONGTATAAN
- 16 July 2023
- Published by Muhammadiyah Metro University in SWARNADWIPA
- Vol. 7 (1)
Open AccessMENINGKATKAN MINAT BELAJAR PESERTA DIDIK MELALUI PENERAPAN MODEL TEAM GAMES TOURNAMENT MEDIA KARTU DOMINO PADA MATA PELAJARAN SEJARAH INDONESIA KELAS XI 11 SMAN 1 GEDONGTATAAN
MENINGKATKAN MINAT BELAJAR PESERTA DIDIK MELALUI PENERAPAN MODEL TEAM GAMES TOURNAMENT MEDIA KARTU DOMINO PADA MATA PELAJARAN SEJARAH INDONESIA KELAS XI 11 SMAN 1 GEDONGTATAAN
- Open Access
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2521-2526
The immediate effects of Porang-processed rice (Amorphophallus muelleri) on triglyceride levels in patients with type 2 diabetes mellitus and dyslipidemia
Link of Video https://youtu.be/HSObtemRZ0M Background: Diabetes Mellitus (DM) is a major cause of death and disability worldwide. Diabetes mellitus is related to metabolic disorders in glucose and lipid levels. Porang tubers contain glucomannan, a substance with many health benefits, such as ameliorating blood glucose and lipid profiles, and has been processed as many food products, such as porang-processed rice (PR). This study investigated the immediate effects of PR on triglyceride levels compared to white rice (WR) in patients with diabetes mellitus (DM) and dyslipidemia. Methods: It was a randomized clinical study with an experimental pre-and post-test control group design held from October to November 2021 in Diponegoro National Hospital, Semarang, Indonesia. A total of 24 study subjects were selected by consecutive sampling. The inclusion criteria were (1) patients diagnosed with diabetes mellitus (DM) or who have been consuming routine oral antidiabetic drugs and (2) have signed the written informed consent. These subjects were divided into 2 groups, i.e., the treatment group (n=12) and the control group (n=12). The treatment group was given a porang rice (PR) diet of 300 grams, 3 times a day, for 5 days. The control group will consume a white rice (WR) diet for 5 days. Triglyceride levels were measured and compared between both groups before and after the treatment. Triglyceride levels were measured using venous blood sampling. All subjects were still consuming routine medications during the study. Results: There were no differences in participants' baseline demographic and clinical characteristics. At pre-treatment, there was no significant difference in triglyceride levels between the group with PR and WR (201.5 ± 102.29 vs 220.8 ± 92.08; respectively, p=0.564). At post-treatment, there was no significant difference in triglyceride levels between the group with PR and that with WR (200.0 ± 90.67 vs 224.3 ± 88.03; respectively, p=0.513). However, there was a larger decrease of triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR (29.4 ± 22.81 vs 12.6 ± 7.12; p=0.016). Conclusion: There were no significant differences in the triglyceride levels before and after porang-processed rice (PR) or white rice (WR) in patients with DM and dyslipidemia. However, there was a larger decrease in triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR. If confirmed by further studies, porang-processed rice might have the role of nutraceutical plants in stabilizing lipid profiles, especially triglyceride levels, in patients with DM and dyslipidemia.
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2521-2526
Open AccessThe immediate effects of Porang-processed rice (Amorphophallus muelleri) on triglyceride levels in patients with type 2 diabetes mellitus and dyslipidemia
Link of Video https://youtu.be/HSObtemRZ0M Background: Diabetes Mellitus (DM) is a major cause of death and disability worldwide. Diabetes mellitus is related to metabolic disorders in glucose and lipid levels. Porang tubers contain glucomannan, a substance with many health benefits, such as ameliorating blood glucose and lipid profiles, and has been processed as many food products, such as porang-processed rice (PR). This study investigated the immediate effects of PR on triglyceride levels compared to white rice (WR) in patients with diabetes mellitus (DM) and dyslipidemia. Methods: It was a randomized clinical study with an experimental pre-and post-test control group design held from October to November 2021 in Diponegoro National Hospital, Semarang, Indonesia. A total of 24 study subjects were selected by consecutive sampling. The inclusion criteria were (1) patients diagnosed with diabetes mellitus (DM) or who have been consuming routine oral antidiabetic drugs and (2) have signed the written informed consent. These subjects were divided into 2 groups, i.e., the treatment group (n=12) and the control group (n=12). The treatment group was given a porang rice (PR) diet of 300 grams, 3 times a day, for 5 days. The control group will consume a white rice (WR) diet for 5 days. Triglyceride levels were measured and compared between both groups before and after the treatment. Triglyceride levels were measured using venous blood sampling. All subjects were still consuming routine medications during the study. Results: There were no differences in participants' baseline demographic and clinical characteristics. At pre-treatment, there was no significant difference in triglyceride levels between the group with PR and WR (201.5 ± 102.29 vs 220.8 ± 92.08; respectively, p=0.564). At post-treatment, there was no significant difference in triglyceride levels between the group with PR and that with WR (200.0 ± 90.67 vs 224.3 ± 88.03; respectively, p=0.513). However, there was a larger decrease of triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR (29.4 ± 22.81 vs 12.6 ± 7.12; p=0.016). Conclusion: There were no significant differences in the triglyceride levels before and after porang-processed rice (PR) or white rice (WR) in patients with DM and dyslipidemia. However, there was a larger decrease in triglyceride levels (Δtriglyceride) in a group with PR compared to that with WR. If confirmed by further studies, porang-processed rice might have the role of nutraceutical plants in stabilizing lipid profiles, especially triglyceride levels, in patients with DM and dyslipidemia.
- Open Access
- 10 May 2023
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 27 (5) , 486−490
Serratus anterior plane block for postoperative analgesia in modified radical mastectomy
Introduction: Serratus Anterior Plane (SAP) block can be used as part of multimodal analgesia, reducing the need for additional analgesia for 24 h postoperatively. The SAP block (SAPB) is easy to apply with a safe technique and low side effects. This study analyzes serratus anterior plane block as postoperative analgesia in Modified Radical Mastectomy (MRM) surgery by assessing the level of pain, side effects, and complications. Methods: This study was a double-blind randomized control trial (RCT) conducted on patients scheduled to undergo MRM, at Dr. Kariadi Hospital Semarang during August-October 2022. A total of 44 patients were enrolled, and divided into two groups; 22 patients in each group. The treatment group received SAPB and was compared with the control group of morphine 0.1 mg/kg, in terms of the numeric pain rating scale, at 4, 8, 12, and 24 h postoperatively, time and number of analgesic rescue doses, the incidence of PONV and pruritus within 24 h postoperatively. Independent T-test, Mann-Whitney, Chi-square, and Fischer tests were performed to analyze the data. P < 0.05 was considered significant. Results: The mean NRS at 4, 12, and 24 h postoperatively was lower in the SAPB group than in the control group (2.73 ± 0.77 vs. 3.23 ± 0.53; 1.77 ± 0.61 vs. 2.32 ± 0.48, and 1.45 ± 0.59 vs. 2.09 ± 0.61). The difference was statistically significant, e.g., P = 0.017, P = 0.003, and P = 0.001, respectively. Time to the first request of rescue analgesia was prolonged in the SAPB group than in the control group (398.86 ± 140.6 vs. 100.91 ± 10.3; P = 0.000). The mean rescue analgesic dose in the SAPB group was lower than in the control group (3.59 ± 1.56 vs. 8.55 ± 2.4; P = 0.000). The control group showed a higher incidence of PONV (68.2% vs. 18.2%, P = 0.01). There was no significant difference in the groups regarding the frequency of pruritus (P = 0.073). Conclusion: Serratus anterior plane block reduced pain significantly up to 24 h postoperatively compared to the control group. The patients in this group needed rescue analgesia after longer duration and needed lower doses of rescue analgesia. There was lower frequency of PONV than the control group. Abbreviations: MRM - Modified Radical Mastectomy; PONV – Postoperative Nausea and Vomiting; PMPS - Post-Mastectomy Pain Syndrome; PVB – Para Vertebral Block; SAP - Serratus Anterior Plane; VAS - Visual Analog Scale Key words: Serratus Anterior Plane Block; Breast Cancer; Modified Radical Mastectomy Citation: Mochamat, Arifin J, Pramadika T, ManapaCH, Istanto W, Wicaksono SA, Nugroho TE. Serratus anterior plane block for postoperative analgesia in modified radical mastectomy. Anaesth. pain intensive care 2023;27(5):486−490; DOI: 10.35975/apic.v27i5.2297 Received: January 05, 2023; Reviewed: January 18, 2023; Accepted: March 31, 2023
- 10 May 2023
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 27 (5) , 486−490
Open AccessSerratus anterior plane block for postoperative analgesia in modified radical mastectomy
Introduction: Serratus Anterior Plane (SAP) block can be used as part of multimodal analgesia, reducing the need for additional analgesia for 24 h postoperatively. The SAP block (SAPB) is easy to apply with a safe technique and low side effects. This study analyzes serratus anterior plane block as postoperative analgesia in Modified Radical Mastectomy (MRM) surgery by assessing the level of pain, side effects, and complications. Methods: This study was a double-blind randomized control trial (RCT) conducted on patients scheduled to undergo MRM, at Dr. Kariadi Hospital Semarang during August-October 2022. A total of 44 patients were enrolled, and divided into two groups; 22 patients in each group. The treatment group received SAPB and was compared with the control group of morphine 0.1 mg/kg, in terms of the numeric pain rating scale, at 4, 8, 12, and 24 h postoperatively, time and number of analgesic rescue doses, the incidence of PONV and pruritus within 24 h postoperatively. Independent T-test, Mann-Whitney, Chi-square, and Fischer tests were performed to analyze the data. P < 0.05 was considered significant. Results: The mean NRS at 4, 12, and 24 h postoperatively was lower in the SAPB group than in the control group (2.73 ± 0.77 vs. 3.23 ± 0.53; 1.77 ± 0.61 vs. 2.32 ± 0.48, and 1.45 ± 0.59 vs. 2.09 ± 0.61). The difference was statistically significant, e.g., P = 0.017, P = 0.003, and P = 0.001, respectively. Time to the first request of rescue analgesia was prolonged in the SAPB group than in the control group (398.86 ± 140.6 vs. 100.91 ± 10.3; P = 0.000). The mean rescue analgesic dose in the SAPB group was lower than in the control group (3.59 ± 1.56 vs. 8.55 ± 2.4; P = 0.000). The control group showed a higher incidence of PONV (68.2% vs. 18.2%, P = 0.01). There was no significant difference in the groups regarding the frequency of pruritus (P = 0.073). Conclusion: Serratus anterior plane block reduced pain significantly up to 24 h postoperatively compared to the control group. The patients in this group needed rescue analgesia after longer duration and needed lower doses of rescue analgesia. There was lower frequency of PONV than the control group. Abbreviations: MRM - Modified Radical Mastectomy; PONV – Postoperative Nausea and Vomiting; PMPS - Post-Mastectomy Pain Syndrome; PVB – Para Vertebral Block; SAP - Serratus Anterior Plane; VAS - Visual Analog Scale Key words: Serratus Anterior Plane Block; Breast Cancer; Modified Radical Mastectomy Citation: Mochamat, Arifin J, Pramadika T, ManapaCH, Istanto W, Wicaksono SA, Nugroho TE. Serratus anterior plane block for postoperative analgesia in modified radical mastectomy. Anaesth. pain intensive care 2023;27(5):486−490; DOI: 10.35975/apic.v27i5.2297 Received: January 05, 2023; Reviewed: January 18, 2023; Accepted: March 31, 2023
- Open Access
- 12 April 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (2) , 1713-1717
Prevalence and characteristics of Postoperative Cognitive Dysfunction (POCD) in on-pump cardiac surgery patients at Dr. Kariadi General Hospital Semarang
Background: Postoperative Cognitive Dysfunction or POCD is a reversible decline in the cognitive function of patients after surgery. The risk factors for POCD are age, comorbidities, duration of CPB, intraoperative hypoperfusion, duration of ventilator use, and postoperative sedation are risk factors of POCD. This study aims to determine the prevalence and characteristics of postoperative cognitive dysfunction (POCD) in patients who undergo on-pump cardiac surgery at Dr. Kariadi General Hospital. Methods: This study's population was all patients undergoing on-pump cardiac surgery at Dr. RSUP. Kariadi in July 2021-December 2021. The study subject was 97 patients, obtained by total sampling technique. The study subjects were examined for cognitive function with MoCA-INA one day before surgery and the third day after surgery. Data were analyzed using SPSS version 23 for Windows. Results: There were 68 (70.1%) patients who experienced POCD and 29 (29.9%) patients who did not experience POCD. The median age of patients with POCD is 50 (18-68) years and 36 (18-63) years for patients without POCD. Based on MAP during CPB, patients with POCD had a median of 64 (51-80) minutes. In patients with POCD, the median length of CPB was 53 (22-92) minutes, and the median length of the aortic cross-clamp clamp was 35 (11-69) minutes. Conclusion: We found a high prevalence of POCD patients after on-pump cardiac surgery, as many as 70.1% at Dr. Kariadi General Hospital.
- 12 April 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (2) , 1713-1717
Open AccessPrevalence and characteristics of Postoperative Cognitive Dysfunction (POCD) in on-pump cardiac surgery patients at Dr. Kariadi General Hospital Semarang
Background: Postoperative Cognitive Dysfunction or POCD is a reversible decline in the cognitive function of patients after surgery. The risk factors for POCD are age, comorbidities, duration of CPB, intraoperative hypoperfusion, duration of ventilator use, and postoperative sedation are risk factors of POCD. This study aims to determine the prevalence and characteristics of postoperative cognitive dysfunction (POCD) in patients who undergo on-pump cardiac surgery at Dr. Kariadi General Hospital. Methods: This study's population was all patients undergoing on-pump cardiac surgery at Dr. RSUP. Kariadi in July 2021-December 2021. The study subject was 97 patients, obtained by total sampling technique. The study subjects were examined for cognitive function with MoCA-INA one day before surgery and the third day after surgery. Data were analyzed using SPSS version 23 for Windows. Results: There were 68 (70.1%) patients who experienced POCD and 29 (29.9%) patients who did not experience POCD. The median age of patients with POCD is 50 (18-68) years and 36 (18-63) years for patients without POCD. Based on MAP during CPB, patients with POCD had a median of 64 (51-80) minutes. In patients with POCD, the median length of CPB was 53 (22-92) minutes, and the median length of the aortic cross-clamp clamp was 35 (11-69) minutes. Conclusion: We found a high prevalence of POCD patients after on-pump cardiac surgery, as many as 70.1% at Dr. Kariadi General Hospital.
- Open Access
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 1041-1048
Clonidine premedication was better in preventing hemodynamic response changes post laryngoscopy and endotracheal intubation compared to fentanyl premedication
Background: Airway control under general anesthesia can be performed using laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation produce mechanical and chemical stimuli that increase sympatho-adrenergic activity, causing an increased hemodynamic response. Various pharmacological and non-pharmacological methods have been used to reduce the response of hemodynamic changes in laryngoscopy and endotracheal intubation, such as fentanyl and clonidine. This study aimed to compare the effectiveness of fentanyl and clonidine in reducing hemodynamic response changes after laryngoscopy and endotracheal intubation. Methods: A double-blind randomized clinical trial was conducted on 48 elective surgery patients in the Surgical Installation of Dr. Kariadi General Hospital and Diponegoro National Hospital Semarang who were planned for laryngoscopy and endotracheal intubation procedures. Subjects were randomized and divided into 2 groups. Group 1 was administered with 2 µg/kgBW intravenous fentanyl premedication and group II was administered with 1 µg/kgBW intravenous clonidine premedication 5 minutes before the laryngoscopy and endotracheal intubation procedure. At baseline and at 1, 3, and 5 minutes after laryngoscopy and endotracheal intubation, the systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded simultaneously. Results: Both fentanyl and clonidine could maintain SBP, DBP, MAP, and HR within normal range. However, clonidine premedication seemed to be better in preventing hemodynamic response changes post-laryngoscopy and endotracheal intubation compared to fentanyl premedication. Clonidine premedication showed lower SBP, DBP, and MAP, but not HR, at the 1st and 3rd-minute post laryngoscopy and endotracheal intubation in comparison with fentanyl premedication (p<0.05). Conclusion: If confirmed by further findings, clonidine premedication may be preferable to prevent hemodynamic changes after laryngoscopy and endotracheal intubation.
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 1041-1048
Open AccessClonidine premedication was better in preventing hemodynamic response changes post laryngoscopy and endotracheal intubation compared to fentanyl premedication
Background: Airway control under general anesthesia can be performed using laryngoscopy and endotracheal intubation. Laryngoscopy and endotracheal intubation produce mechanical and chemical stimuli that increase sympatho-adrenergic activity, causing an increased hemodynamic response. Various pharmacological and non-pharmacological methods have been used to reduce the response of hemodynamic changes in laryngoscopy and endotracheal intubation, such as fentanyl and clonidine. This study aimed to compare the effectiveness of fentanyl and clonidine in reducing hemodynamic response changes after laryngoscopy and endotracheal intubation. Methods: A double-blind randomized clinical trial was conducted on 48 elective surgery patients in the Surgical Installation of Dr. Kariadi General Hospital and Diponegoro National Hospital Semarang who were planned for laryngoscopy and endotracheal intubation procedures. Subjects were randomized and divided into 2 groups. Group 1 was administered with 2 µg/kgBW intravenous fentanyl premedication and group II was administered with 1 µg/kgBW intravenous clonidine premedication 5 minutes before the laryngoscopy and endotracheal intubation procedure. At baseline and at 1, 3, and 5 minutes after laryngoscopy and endotracheal intubation, the systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded simultaneously. Results: Both fentanyl and clonidine could maintain SBP, DBP, MAP, and HR within normal range. However, clonidine premedication seemed to be better in preventing hemodynamic response changes post-laryngoscopy and endotracheal intubation compared to fentanyl premedication. Clonidine premedication showed lower SBP, DBP, and MAP, but not HR, at the 1st and 3rd-minute post laryngoscopy and endotracheal intubation in comparison with fentanyl premedication (p<0.05). Conclusion: If confirmed by further findings, clonidine premedication may be preferable to prevent hemodynamic changes after laryngoscopy and endotracheal intubation.